According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
Here is a look at Alzheimer’s disease, a progressive brain disorder that leads to loss of memory and other intellectual abilities. Facts Alzheimer’s disease is the most common form of dementia, which ...
Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health, discusses findings from the TROPION-Breast01 study on ...
NEW YORK - OS Therapies, Inc. (NYSE-A: OSTX), a small-cap biotech firm with a market capitalization of $42 million focusing on cancer treatment solutions, has announced the completion of its Phase 2b ...
Hosted on MSN1d
HOLX's New Offerings Likely to Revive Stock Amid Macro WoesHologic HOLX has been gaining from new strategic product launches across Diagnostics and Breast Health. However, ...
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Q1 2025 Earnings Call Transcript February 12, 2025 NeuroOne Medical Technologies Corporation beats earnings expectations. Reported EPS is ...
Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.
More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...
To support the development of next-gen therapies, including GLP-1 drugs for diabetes and obesity.
On the back of US contract wins, home-grown radiology giant Pro Medicus reports a record December half with the promise of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback